Australian Doctor 
 News

Australia to trial immunoglobulin treatment for COVID-19

The therapy will be made from plasma donated by recovered patients, researchers say
0
6 May 2020
Save
ClosePlease login

Patients who have recovered from COVID-19 will be urged to donate plasma for a landmark trial in a bid to find an effective antibody-based treatment against the virus.

CSL Behring Australia announced it will begin developing a concentrated, “hyperimmune globulin” plasma product, dubbed ‘COVID-19 Immunoglobulin’, to be used in hospitalised patients with serious complications of the illness.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .